Detalhe da pesquisa
1.
Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!
Eur J Cancer
; 165: 169-173, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245863
2.
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.
Clin Cancer Res
; 27(24): 6815-6823, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583970
3.
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer.
Cancers (Basel)
; 12(9)2020 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32872561